Literature DB >> 29152480

Expanding the boundaries of Milan.

Catherine Garcia1, Luis F Acosta1, Roberto Gedaly1.   

Abstract

Year:  2017        PMID： 29152480      PMCID： PMC5673754          DOI： 10.21037/hbsn.2017.05.11

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  14 in total

1.  Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18.

Authors:  Yumei Du; Guangyao Kong; Xiaona You; Shuai Zhang; Tao Zhang; Yuen Gao; Lihong Ye; Xiaodong Zhang
Journal:  J Biol Chem       Date:  2012-06-08       Impact factor: 5.157

2.  Cancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma.

Authors:  Valery Vilchez; Lilia Turcios; Yekaterina Zaytseva; Rachel Stewart; Eun Y Lee; Erin Maynard; Malay B Shah; Michael F Daily; Ching-Wei D Tzeng; Daniel Davenport; Ana Lia Castellanos; Steven Krohmer; Peter J Hosein; Bernard Mark Evers; Roberto Gedaly
Journal:  Am J Surg       Date:  2016-02-27       Impact factor: 2.565

3.  Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.

Authors:  Patrick P McHugh; Jeffrey Gilbert; Santiago Vera; Alvaro Koch; Dinesh Ranjan; Roberto Gedaly
Journal:  HPB (Oxford)       Date:  2010-02       Impact factor: 3.647

Review 4.  Role of liver transplantation for hepatocellular carcinoma.

Authors:  Vinay Kumaran
Journal:  J Clin Exp Hepatol       Date:  2014-01-23

5.  Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria.

Authors:  Jeong-Hoon Lee; Yuri Cho; Hwi Young Kim; Eun Ju Cho; Dong Hyeon Lee; Su Jong Yu; Jae Woo Lee; Nam-Joon Yi; Kwang-Woong Lee; Seoung Hoon Kim; Jong Man Kim; Jae-Won Joh; Lewis W Teperman; James S Park; Yoon Jun Kim; Kyung-Suk Suh; Jung-Hwan Yoon
Journal:  Ann Surg       Date:  2016-05       Impact factor: 12.969

6.  Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.

Authors:  Francis Y Yao; Robert K Kerlan; Ryutaro Hirose; Timothy J Davern; Nathan M Bass; Sandy Feng; Marion Peters; Norah Terrault; Chris E Freise; Nancy L Ascher; John P Roberts
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

7.  Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.

Authors:  Hao-Hsien Lee; Yih-Huei Uen; Yu-Feng Tian; Chi-Shu Sun; Ming-Jen Sheu; Hsing-Tao Kuo; Lok-Beng Koay; Ching-Yih Lin; Ching-Cherng Tzeng; Chia-Ju Cheng; Ling-Yu Tang; Sun-Lung Tsai; Andrew H-J Wang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

8.  An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.

Authors:  Shawn J Pelletier; Sherry Fu; Veena Thyagarajan; Carlos Romero-Marrero; Mashal J Batheja; Jeffrey D Punch; John C Magee; Anna S Lok; Robert J Fontana; Jorge A Marrero
Journal:  Liver Transpl       Date:  2009-08       Impact factor: 5.799

Review 9.  Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma.

Authors:  Ranjit Chauhan; Nivedita Lahiri
Journal:  Biomark Cancer       Date:  2016-07-04

Review 10.  Tumor markers for hepatocellular carcinoma.

Authors:  Yan-Jie Zhao; Qiang Ju; Guan-Cheng Li
Journal:  Mol Clin Oncol       Date:  2013-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.